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A 34-year-old patient with diabetes insipidus after
removal of a hypothalamic tumor, developed difficulties
with his treatment and presented with hypernatremia. On
admission his blood pressure was normal, he was confused,
had polyuria and secondary hyperaldosteronism, and his
serum [Naþ ] was 162mmol/l. We lowered the serum [Naþ ]
with free water and desmopressin so that after 13 days
his serum [Naþ ] was 141mmol/l and his symptoms were
improved. We reviewed the patient’s charts and discovered
that his body weight was 79.0 kg with hypernatremia, and
78.5 kg after correction of his serum [Naþ ] and aldosterone.
The ability to clinically measure Naþ in muscle and skin
with 23Na magnetic resonance imaging (MRI) enabled us to
gain insight into Naþ disposition in the patient. A 23Na-MRI
of the calf muscle from the hypernatremic patient (Figure 1a)
followed by the same image at the site after correction (Figure
1b) showed a visible decrease in muscle Naþ content.
According to our standards, these changes are consistent with
a 34 to 23mmol/l decrease in muscle Naþ concentration
(muscle Naþ content in control group: 19mmol/l).1
Our findings raise the hypothesis that aberrancies in the
serum Naþ concentration coupled with renal water loss are
associated with unexpected large shifts of Naþ inside and
outside of skeletal muscle. We have found similar shifts
previously in patients with primary hyperaldosteronism and
in experimental desoxycorticosterone acetate salt models
with volume overload.1,2 We speculate that not only volume
status, but aldosterone levels also might be mechanistically
relevant for the observed Naþ shift into muscle. Because
we quantified Naþ content relative to muscle volume, we
conclude that the Naþ shift is not paralleled by commensu-
rate water retention.
The findings could serve to explain why equated
predictions of serum [Naþ ] change with therapy, which
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Figure 1 | 23Na magnetic resonance imaging of calf
muscle. A patient with hypernatremia before (a) and after
(b) correction to a normal serum Naþ concentration. The
standards are below the calf muscle and contain Naþ
concentrations of 10, 20, 30, and 40mmol/l. A remarkable
decrease in the muscle Naþ content occurs with correction of
serum Naþ concentration, plasma renin, and serum
aldosterone.
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usually solely focus on correcting a water deficit or surplus,3
are not always crowned with success. Our data suggest that
hypernatremia, even in case of most obvious defects in renal
water excretion, is a disorder in water balance and body Naþ
distribution. To date, no clinical method has been established
for quantification of electrolyte redistribution in patients.
Functional 23Na-MRI offers a nonhazardous, noninvasive
method to quantify such Naþ shifts. Our understanding of
dysnatremias will be expanded accordingly.
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